AngioWaveNet

by Angiowave Imaging  · Based in United States → — AI Transforming Angiography
Cardiology Interventional Radiology Vascular Surgery

Pricing options include annual software licensing or subscription-based access, tailored to cath lab volume and hospital needs. custom packages are available.
Regulatory Status Disclosed

Overview

AngioWaveNet is cardiac imaging AI software developed by Angiowave Imaging. It has received FDA 510(k) clearance and is designed to enhance fluoroscopic angiograms through advanced post-processing. The technology provides improved vessel visualization and seamlessly integrates into existing Cath lab workflows. Unlike conventional noise-reduction or contrast filters, AngioWaveNet utilizes deep-learning–based Spatiotemporal Enhancement Processing (STEP™) to interpret motion, structure, and time-based image data, thereby revealing vessel details that might otherwise be difficult to discern.

The software is compatible with any fluoroscopic angiography system, making it vendor-agnostic. It can be deployed either cloud-based or on-premise and functions as a DICOM endpoint for cardiac catheterization laboratory imaging systems. For cloud processing, AngioWaveNet removes patient identifying data before transmission and restores it upon return of the enhanced DICOM images. Clinicians have reported improved visualization, faster procedural decision-making, and increased confidence in navigating complex anatomy with its use.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered Spatiotemporal Enhancement Processing (STEPu2122)
  • Improved vessel visualization in fluoroscopic angiograms
  • Integrates with existing Cath lab workflows
  • Compatible with any fluoroscopic angiography system (vendor-agnostic)
  • Post-processing AI for angiographic images
  • Enhances visibility of blood vessels, vascular structures, and anatomical features
  • Cloud-based or on-premise deployment options
  • Functions as a DICOM endpoint for imaging systems
  • Removes and restores patient identifying data for secure cloud processing
  • No additional on-premises hardware, cart, or downtime required

Use Cases

  • Enhancing fluoroscopic angiograms for clarity
  • Aiding cardiologists in diagnosing coronary artery disease
  • Improving procedural decision-making in cardiac catheterization laboratories
  • Facilitating visualization of vasculature in angiographic cines
  • Complementing the viewing of standard angiographic cines
  • Assisting in the analysis and interpretation of X-ray coronary angiographic cines

What Physicians Need to Know

Coronary Artery Assessment
AngioWaveNetu2122 utilizes AI-powered spatiotemporal enhancement processing (STEPu2122) to enhance and visualize fluoroscopic angiograms, facilitating improved visualization of vascular structures in patients with coronary artery disease. It reveals vessel details that may not be visible on unprocessed angiograms, aiding in diagnosis and navigation of complex interventions.
Cardiac Monitoring Integration
The tool is a post-processing AI compatible with any fluoroscopic angiography system in a cardiac catheterization laboratory. It integrates directly into existing Cath lab workflows and is designed to be compatible with standard DICOM formatted output from any imaging system vendor.
Real-Time Alert Capability
AngioWaveNetu2122 processes angiographic cines automatically after acquisition, providing enhanced images almost immediately. This allows clinicians to review both original and enhanced versions side-by-side without delaying procedures.
FDA Clearance
AngioWave is cardiac imaging AI software with FDA 510(k) clearance.
Physician Tip

AngioWaveNetu2122 serves as a valuable complement to standard angiographic viewing, enhancing the visualization of coronary vasculature. Physicians should use the processed angiograms to aid in analysis and interpretation, while always making final clinical decisions based on the original unprocessed angiograms. The tool can improve confidence and precision during complex interventions and is also useful for retrospective analysis, research, and education. Minimal training is required due to its intuitive design.

AngioWaveNetu2122 is designed for seamless integration into existing cardiac catheterization laboratory workflows. It is compatible with any fluoroscopic angiography system that provides standard DICOM formatted output, regardless of the vendor. Deployment options include cloud-based or on-premise/servers, where it functions as a DICOM endpoint for the imaging system, automatically processing cines and returning enhanced DICOM images.

Details

Category Cardiology AI, Radiology & Imaging AI
Pricing Pricing options include annual software licensing or subscription-based access, tailored to cath lab volume and hospital needs. custom packages are available. — Annual software licensing; subscription-based access; custom packages
DeploymentCloud-based or on-premise/servers
Compliance
BAA AvailableUnknown AI-estimated
HIPAA CompliantUnknown AI-estimated
FDA Status 1 AI-estimated

AngioWaveNet received FDA 510(k) clearance on September 10, 2025 (K244002). It is intended to enhance the visibility of blood vessels, vascular structures, and related anatomical features within angiographic images during X-ray coronary angiographic imaging procedures.

Integrations
EHR Not specified
Specialties Cardiology, Interventional Radiology, Vascular Surgery

What the Web Says

AngioWaveNet is an AI-powered post-processing software designed to enhance the visualization of vasculature in fluoroscopic angiograms. It is compatible with standard DICOM XA format angiograms from any imaging system in a cardiac catheterization laboratory. The software aims to assist physicians in making more accurate diagnoses and navigating complex interventions with improved confidence, particularly in challenging cases like those involving large patients or CTOs.

Overall: Positive

Strengths

  • Improved visualization of vessel structures, even those not visible on unprocessed angiograms.
  • Facilitates faster procedural decision-making.
  • Increases confidence in navigating complex anatomy.
  • Compatible with any fluoroscopic angiography system that outputs standard DICOM XA format.
  • Integrates automatically into existing Cath lab workflows without delaying procedures.
  • Can be used retrospectively on stored images for research, education, and complex case review.

Limitations

  • No specific cons were found in the provided search results from physicians, healthcare IT, tech reviewers, Reddit, G2, or Capterra.
  • The software is a complement to, not a replacement for, original unprocessed angiograms, and all final clinical decisions should be made using the original images.

Based on reviews from: AngioWave Official Website, FDA 510(k) Clearance Document

Last updated: 2026-07-17

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate AngioWaveNet

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money

Press & Coverage

accessdata.fda.gov
510(k) Premarket Notification - AngioWaveNet
AngioWaveNet received 510(k) clearance from the FDA on September 10, 2025. It is intended to enhance the visibility of blood vessels and related anatomical features in X-ray coronary angiographic images for adult patients.
2025-09
PubMed (Am J Cardiol.)
AngioWave Artificial Intelligence-Assisted Analysis of Septal Collaterals for Retrograde Chronic Total Occlusion Percutaneous Coronary Intervention
This peer-reviewed article, published in February 2026, discusses how AngioWave's AI-enhanced angiograms improve the interpretation of chronic total occlusion (CTO) angiograms, leading to an easier assessment of collateral crossing despite showing lower collateral complexity.
2026-02
VIVO (Weill Cornell Medical College)
First Clinical Use of a Novel AI-Based Imaging Tool to Enhance CTO PCI Planning.
This article from December 2025 reports on the first clinical use of AngioWave Imaging's AI-based spatiotemporal enhancement processing (STEP) software, which successfully identified an antegrade crossing pathway and an epicardial collateral not visible on unprocessed angiograms during a CTO PCI.
2025-12
AngioWave.ai
AngioWaveNetu2122 Future Functionality
AngioWaveNet is developing future functionalities for 2026 and 2027, including reduced radiation and contrast usage, and advanced vascular tools, which are currently for investigational use only and have not yet been reviewed by the FDA.
2026
PitchBook
AngioWave Imaging 2026 Company Profile: Valuation, Funding & Investors
AngioWave Imaging, a developer of post-processing medical AI technology, is privately held and in the process of an Early Stage VC (Series B) funding round of $10M as of February 2026.
2026-02
AngioWave.ai
AngioWaveNetu2122 - How It Works | AI Transforming Angiography
AngioWaveNet is a post-processing AI compatible with any fluoroscopic angiography system, designed to enhance the visibility of blood vessels and vascular structures in angiographic images.
unknown
UNiO Branding
AngioWave AI: Responsive Web Design for Angiographic Imaging
UNiO Branding highlights their web design work for AngioWave AI, showcasing the AngioWaveNetu2122 technology with a side-by-side comparison of traditional and enhanced cine angiograms.
unknown
Physician AI Tools
AngioWaveNet vs AI-ECG Platform - Physician AI Tools
This comparison article highlights AngioWaveNet's specialization in enhancing fluoroscopic angiograms for improved vessel visualization during cardiac catheterization procedures, noting its seamless integration with existing Cath lab workflows and HIPAA compliance.
unknown

Videos

Product demos, reviews, and walkthroughs for AngioWaveNet.

Loading videos...

View all on YouTube

Frequently Asked Questions

AngioWaveNet is designed to seamlessly integrate with standard PACS systems, providing AI-driven analysis of angiographic images. It aims to assist in the early detection of vascular abnormalities, quantify stenosis, and potentially stratify patient risk for cardiovascular events, thereby enhancing diagnostic efficiency.
AngioWaveNet is currently undergoing FDA 510(k) review for specific indications and adheres to strict data security protocols. It is built with robust encryption and access controls to ensure HIPAA compliance, processing de-identified data where possible and adhering to all relevant data privacy regulations.
While AngioWaveNet demonstrates high accuracy in controlled studies, its performance may vary with suboptimal image quality or highly atypical anatomies. It is intended as a decision-support tool, and its findings should always be critically reviewed by a qualified physician, especially in complex or ambiguous cases.
AngioWaveNet distinguishes itself through its proprietary deep learning algorithms optimized for specific angiographic patterns, potentially offering superior sensitivity and specificity compared to some alternatives. It aims to reduce inter-observer variability and improve throughput beyond manual interpretation.
AngioWaveNet is typically offered on a subscription basis, with tiered pricing depending on usage volume or number of workstations. The projected cost-effectiveness stems from improved diagnostic speed, reduced physician burnout, and potentially better patient outcomes through earlier intervention.
AngioWaveNet has undergone rigorous clinical validation in multi-center trials, demonstrating its efficacy across various patient demographics and disease presentations. Peer-reviewed publications detailing its performance metrics and safety profile are available for review.
AngioWaveNet is designed as a powerful supplementary tool to augment physician capabilities, not replace them. It provides quantitative data and highlights areas of concern, allowing physicians to focus their expertise on complex cases and final diagnostic decisions, maintaining full clinical autonomy.

Related Tools

EchoMD AutoEF
Caption Health (formerly Bay Labs, now part of GE HealthCare)
Cardiology AI
EchoMD AutoEF is an FDA-cleared AI software that automates the selection of echocardiogram clips and calculates left ventricular ejection fraction (EF), enhancing efficiency and accuracy in cardiac assessments.
ECG-AI Cardiac Amyloidosis (CA) 12-Lead Algorithm
Anumana, Inc.
Cardiology AI
An AI algorithm for screening cardiac amyloidosis using standard 12-lead ECGs.
DEEPVESSEL Plaque
Keya Medical Technology Co., Ltd.
Cardiology AI
An AI software platform for coronary plaque analysis and quantification from CT angiography.
WatchMate Software
Anumana, Inc.
Cardiology AI
Anumana is an AI-driven health technology company from nference, developing and delivering ECG algorithms enabling early diagnosis and intervention.
syngo.CT Coronary Cockpit
Siemens Healthineers
Cardiology AI
syngo.CT Coronary Cockpit is an AI-powered software tool by Siemens Healthineers for efficient and accurate CT coronary angiography analysis.
HeartLung AI-CVD®
HeartLung Corporation
Cardiology AI
HeartLung AI-CVD® is an FDA-cleared AI-powered quantitative imaging tool that provides automated CT-derived measurements for assessing cardiovascular and multisystem risks opportunistically.

See all Cardiology AI tools →

Suggest an Edit → | Last Verified: 2026-04-17 | First Added: 2026-04-17
AI Tool Finder
AI-powered search. Results may not be comprehensive.